Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving RH and its officers or directors [1] Group 1: Financial Performance and Allegations - Hunterbrook Media published a report on January 24, 2025, alleging that RH may be "running out of money" and highlighted a cumulative shortfall of $1.4 billion in free cash flow over the last 20 quarters [3] - The report also stated that RH's claims of rapid growth appear to be unsubstantiated, leading to a stock price decline of $15.72 per share, or 3.6%, closing at $418.74 on the same day [3] Group 2: Legal Context - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [4] - The firm has a legacy of recovering multimillion-dollar damages for class members, continuing the tradition established by its founder, Abraham L. Pomerantz [4]

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ready Capital Corporation ("Ready Capital" or the "Company") (NYSE: RC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ready Capital investors who were adversely affected by alleged securities fraud between August 8, 2024 and March 2, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ready-capita ...

Core Insights - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving iRobot Corporation and its officers or directors [1] - iRobot reported a significant financial loss in Q4 2024, with a loss of $2.06 per share and revenue of $172 million, marking a 44% year-over-year decline [3] - Following the financial report, iRobot's stock price dropped by $3.255 per share, or 51.58%, closing at $3.055 per share on March 13, 2025 [3] Financial Performance - iRobot's Q4 2024 results showed a loss of $2.06 per share [3] - Revenue for the quarter was reported at $172 million, reflecting a 44% decline compared to the previous year [3] - The company expressed substantial doubt about its ability to continue as a going concern for at least 12 months from the issuance of its 2024 financial statements [3] Market Reaction - iRobot's stock experienced a significant decline of 51.58% over two trading sessions following the release of its financial results [3] - The stock price fell from its previous value to close at $3.055 per share [3]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving XP Inc. and its officers or directors [1] Group 1: Investigation and Allegations - Pomerantz LLP is representing investors of XP Inc. in an investigation regarding possible securities fraud [1] - Grizzly Research published a report alleging that XP is operating a Ponzi scheme through derivatives sales misrepresented as proprietary trading profits [3] - Following the report's release, XP's stock price dropped by $0.82, or 5.48%, closing at $14.14 per share on March 12, 2025 [3] Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for victims of securities fraud [4] - The firm has successfully recovered numerous multimillion-dollar damages awards for class members [4]

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sarepta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Ma ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether 3D Systems and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On M ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Adverum Biotechnologies, Inc. following the company's announcement of the need to restate its financial statements due to accounting errors [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of Adverum and is looking into claims of securities fraud or other unlawful practices by the company and its officers/directors [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the class action [2]. Group 2: Financial Disclosure - On March 31, 2025, Adverum disclosed that certain previously issued financial statements should no longer be relied upon due to non-cash errors related to tenant improvement allowances for an operating lease in North Carolina [3]. - The company announced it will restate its financial statements for the years ended December 31, 2022, and 2023, as well as for the quarterly periods in 2023 and 2024 [3]. - Following this announcement, Adverum's stock price dropped by $0.54, or 12.36%, closing at $3.83 per share on April 1, 2025 [3].

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether TechTarget and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Apri ...

Core Viewpoint - A lawsuit has been filed against Ready Capital Corporation and its senior executives for potential violations of federal securities laws, focusing on misrepresentation of the company's financial health due to non-performing loans in its commercial real estate portfolio [1][2][4]. Group 1: Company Overview - Ready Capital is a real estate finance company that originates, acquires, finances, and services lower-to-middle-market commercial real estate loans, small business administration loans, and other real estate-related investments [3]. Group 2: Legal Allegations - The lawsuit alleges that the defendants misrepresented the severe impact of significant non-performing loans on Ready Capital's business, which were not accurately reflected in the company's expected credit loss or valuation allowances [4]. - The complaint is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Ready Capital stock [2]. Group 3: Financial Impact - On March 3, 2025, Ready Capital announced a financial charge of $382 million, including $284 million related to non-performing loans, and a reduction in its dividend to $0.125 per share [5]. - Following this announcement, Ready Capital's stock price fell nearly 27%, from $6.93 per share on February 28, 2025, to $5.07 per share on March 3, 2025 [6].

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc. Investors have until June 10, 2025, to ask the Court to be ...